[The results of using plasmapheresis in the acute rejection reaction after kidney transplants].
We report about the results of plasmapheresis treatment of acute vascular rejection in patients after renal transplantation and compare this group of cadaveric-kidney recipients with another group of patients with acute vascular rejection that got only treatment with intensified immunosuppression (cyclophosphamide). The retrospective study was provided in a non-randomized form with 27 patients in the combined plasmapheresis-cyclophosphamide group and 31 patients in the cyclophosphamide group. The advantages and disadvantages of plasmapheresis treatment in acute rejection periods are discussed. Special attention is given to infectious complications in the early posttransplant period.
von Appen
K
K
Bast
R
R
Schmitt
E
E
Nizze
H
H
D005069:Evaluation Studies as Topic; D005859:Germany, East / Q000453:epidemiology; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000706:statistics & numerical data; D010956:Plasmapheresis / Q000706:statistics & numerical data; D012189:Retrospective Studies; D013997:Time Factors
Rezul'taty primeneniia plazmafereza pri reaktsii ostrogo ottorzheniia posle transplantatsiĭ pochek.